Opthea Limited (OPTEY)
OTCMKTS · Delayed Price · Currency is USD
0.0717
+0.0384 (115.17%)
At close: Dec 17, 2025
Opthea Market Cap
Opthea has a market cap or net worth of $466.57 million as of December 17, 2025. Its market cap has increased by 55.77% in one year.
Market Cap
466.57M
Enterprise Value
559.27M
Revenue
146.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since May 13, 1996, Opthea's market cap has increased from 31.49M to 466.57M, an increase of 1,381.68%. That is a compound annual growth rate of 9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 14, 2025 | 466.57M | -24.40% |
| Dec 31, 2024 | 617.19M | 139.65% |
| Dec 29, 2023 | 257.53M | -11.31% |
| Dec 30, 2022 | 290.38M | -12.38% |
| Dec 31, 2021 | 331.39M | -33.74% |
| Dec 31, 2020 | 500.17M | -11.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |